XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues $ 5,175 $ 5,704 $ 15,260 $ 17,100
Cost of revenues 3,136 3,613 9,547 10,745
Gross profit 2,039 2,091 5,713 6,355
Operating expenses:        
General & administrative 1,882 2,200 5,261 5,291
Marketing & selling 580 723 1,943 2,258
Research & development 172 275 570 859
Total Operating expenses 2,634 3,198 7,774 8,408
Operating loss (595) (1,107) (2,061) (2,053)
Other (expense) income:        
Settlements 0 0 (2) (500)
Other expense (11) 0 (13) (9)
Total other expense (11) 0 (15) (509)
Loss before provision (benefit from) income taxes (606) (1,107) (2,076) (2,562)
Provision for (benefit from) income taxes (71) 992 (26) 647
Net loss $ (535) $ (2,099) $ (2,050) $ (3,209)
Basic and Diluted net loss per share (in dollars per share) $ (0.09) $ (0.36) $ (0.35) $ (0.56)
Weighted average common shares outstanding, basic and diluted (in shares) 5,894 5,755 5,827 5,718